Introduction

MPS IV – Validation and Applications

MPS IV – Validation and Applications

Overview

Massively parallel sequencing (MPS) is an exciting technology that holds promise for enhancing the capabilities of the forensic DNA analyst. However, there are several challenges that confront implementation of an MPS system into the crime laboratory, which include: training and education on fundamentals of the chemistry, functionality, and genetic marker systems; validation criteria and study design; policy and data procedure developments related to CODIS operations; and perceived admissibility and privacy issues. This four-part webinar series will address these and other areas of interest, providing foundational information on the two available MPS systems, covering platforms and chemistries, throughput, genetic markers, bioinformatics, validation requirements, applications, and potential admissibility issues.

In this fourth webinar, Validation and Applications, the discussion focus on the potential validation requirements needed to derive resolutions to pending issues of MPS implementation, including legality and CODIS considerations. Successful examples of MPS application and lessons learned from previous technology platforms are highlighted in order to determine the next steps for forensic adoption.

A certificate of completion is available for all who register and attend this webinar.

Presenters

  • Bruce Budowle
  • Tom Callaghan
  • Rock Harmon
  • Brian Young
  • Walther Parson
  • Sara Katsanis
  • Jonathan King
  • Patricia Melton

Funding for this Forensic Technology Center of Excellence webinar has been provided by the National Institute of Justice, Office of Justice Programs, U.S. Department of Justice.

The opinions, findings, and conclusions or recommendations expressed in this webinar are those of the presenter(s) and do not necessarily reflect those of the U.S. Department of Justice.

Contact us at ForensicCOE@rti.org with any questions and subscribe to our newsletter for notifications.


Related Content

Success Story: NIJ and The New York City OCME Validating Confirmatory Body Fluid Identification Assays for Real-World Impact

National Institute of Justice and The New York City OCME Date December 2023 Overview Support from the National Institute of Justice (NIJ) enabled the New York City OCME to develop and validate proteomic mass spectrometry body fluid assays to support…

What Medical Examiner’s and Coroner’s Offices Should Know about Molecular Autopsy

Date December 2023 Overview A molecular autopsy consists of “postmortem genetic testing of decedents who died naturally, suddenly, and unexpectedly at young ages.” Molecular autopsies can enable a more accurate determination of cause of death in cases where the scene…

FLN-TWG: A Roadmap to Improve Research and Technology Transition in Forensic Science

← Back to FLN-TWG Main Page  Forensic Laboratory Needs Technology Working Group (FLN-TWG) The National Institute of Justice (NIJ), in partnership with the Forensic Technology Center of Excellence (FTCOE) at RTI International, formed the Forensic Laboratory Needs Technology Working Group…